Jim Simons acquired 6.73 Million Corcept Therapeutics shares worth $149 Million. That's 0.23% of their equity portfolio (85th largest holding). The investor owns 6.37% of the outstanding Corcept Therapeutics stock. The first Corcept Therapeutics trade was made in Q1 2015. Since then Jim Simons bought shares 21 more times and sold shares on fourteen occasions. The stake costed the investor $86.8 Million, netting the investor a gain of 72% so far.